Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siew Ching Ngai

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Drug Targets|March 3, 2020
Curcumin Sensitizes Cancers Towards TRAIL-induced Apoptosis via Extrinsic and Intrinsic Apoptotic PathwaysSiew Ching Ngai
Gene|February 19, 2024
E-cadherin re-expression: Its potential in combating TRAIL resistance and reversing epithelial-to-mesenchymal transitionSer Hui San, Siew Ching Ngai
Biotechnology & Genetic Engineering Reviews|December 6, 2018
Silencing of transgene expression in mammalian cells by DNA methylation and histone modifications in gene therapy perspectiveSuleiman Yusuf Alhaji, Siew Ching Ngai, Syahril Abdullah
Biomed Research International|May 12, 2015
DNA methylation and histone modifications are the molecular lock in lentivirally transduced hematopoietic progenitor cellsSiew Ching Ngai, Rozita Rosli, Akram Al Abbar, et al.
Gene|October 15, 2013
Transgene expression from CpG-reduced lentiviral gene delivery vectors in vitroPoh Tee Low, Mei I Lai, Siew Ching Ngai, et al.
Gene|February 28, 2012
Lentivirus vector driven by polybiquitin C promoter without woodchuck posttranscriptional regulatory element and central polypurine tract generates low level and short-lived reporter gene expressionSiew Ching Ngai, Rozita Rosli, Norshariza Nordin, et al.
Bioresearch Open Access|May 6, 2020
Induced Pluripotent Stem Cells: Reprogramming Platforms and Applications in Cell Replacement TherapyAkram Al Abbar, Siew Ching Ngai, Nadine Nograles, et al.
Current Cancer Drug Targets|June 27, 2025
Elucidating the Potential of E-cadherin Re-expression along with Trichostatin A and Zebularine in Enhancing Tumour Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis in Human Breast Adenocarcinoma CellsSer Hui San, Sonia How Ming Wong, Chee Mun Fang, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 16, 2022
Trailing TRAIL Resistance in Human Breast Adenocarcinoma Cells with Trichostatin A and ZebularineSonia How Ming Wong, Chee-Mun Fang, Hwei-San Loh, et al.
Anti-Cancer Agents in Medicinal Chemistry|June 9, 2021
Anti-Cancer Effects of Epigenetics Drugs Scriptaid and Zebularine in Human Breast Adenocarcinoma CellsZhi Hung Yap, Wei Yang Kong, Abdur Rahmaan Azeez, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Drug Targets|March 3, 2020
Curcumin Sensitizes Cancers Towards TRAIL-induced Apoptosis via Extrinsic and Intrinsic Apoptotic PathwaysSiew Ching Ngai
Gene|February 19, 2024
E-cadherin re-expression: Its potential in combating TRAIL resistance and reversing epithelial-to-mesenchymal transitionSer Hui San, Siew Ching Ngai
Biotechnology & Genetic Engineering Reviews|December 6, 2018
Silencing of transgene expression in mammalian cells by DNA methylation and histone modifications in gene therapy perspectiveSuleiman Yusuf Alhaji, Siew Ching Ngai, Syahril Abdullah
Biomed Research International|May 12, 2015
DNA methylation and histone modifications are the molecular lock in lentivirally transduced hematopoietic progenitor cellsSiew Ching Ngai, Rozita Rosli, Akram Al Abbar, et al.
Gene|October 15, 2013
Transgene expression from CpG-reduced lentiviral gene delivery vectors in vitroPoh Tee Low, Mei I Lai, Siew Ching Ngai, et al.
Gene|February 28, 2012
Lentivirus vector driven by polybiquitin C promoter without woodchuck posttranscriptional regulatory element and central polypurine tract generates low level and short-lived reporter gene expressionSiew Ching Ngai, Rozita Rosli, Norshariza Nordin, et al.
Bioresearch Open Access|May 6, 2020
Induced Pluripotent Stem Cells: Reprogramming Platforms and Applications in Cell Replacement TherapyAkram Al Abbar, Siew Ching Ngai, Nadine Nograles, et al.
Current Cancer Drug Targets|June 27, 2025
Elucidating the Potential of E-cadherin Re-expression along with Trichostatin A and Zebularine in Enhancing Tumour Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis in Human Breast Adenocarcinoma CellsSer Hui San, Sonia How Ming Wong, Chee Mun Fang, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 16, 2022
Trailing TRAIL Resistance in Human Breast Adenocarcinoma Cells with Trichostatin A and ZebularineSonia How Ming Wong, Chee-Mun Fang, Hwei-San Loh, et al.
Anti-Cancer Agents in Medicinal Chemistry|June 9, 2021
Anti-Cancer Effects of Epigenetics Drugs Scriptaid and Zebularine in Human Breast Adenocarcinoma CellsZhi Hung Yap, Wei Yang Kong, Abdur Rahmaan Azeez, et al.
Pageof 2